5th Annual Genome Editing Congress

7 November, 2019 - 8 November, 2019

1 Shortlands, Hammersmith, International Ctre Hammersmith, W6 8DR

General Information

600+ senior-level delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies.

20+ case studies and presentations focused on the latest developments in gene editing techniques and case studies on the therapeutic applications of genome editing technologies.

Including 2 Interactive Streams: 

  • Genome Editing Techniques and Technologies
  • Therapeutic Applications of Genome Editing

View Agenda: https://bit.ly/2s1kWe7

Co-located with the established 11th Annual Next Generation Sequencing & Clinical Diagnostics Congress7th Annual Single Cell Analysis Congress, 2nd Synthetic Biology Congress and the Digital PCR Congress.

For more information contact b.copeman@oxfordglobal.co.uk.

Go Social: Join our Genomics Networking Group on LinkedIn, follow us on Twitter @xgenseq & join the conversation at #GENSERIESUK19

 

2019 Live Webinar

Applications of CRISPR/Cas9 in studying disease mechanisms

Presented by Kristine Freude, Associate Professor & Director of BrainStem – Center for Excellence in Neuroscience, University of Copenhagen and Yonglun Luo, Group Leader, Aarhus University

Tuesday October 1st, 2019 at 10:00am BST

Register for Free: https://bit.ly/2JFbVA7

 

Benefits of Attending

  • An overview of the current available tools (repair, knockin, activation and repression of disease genes)
  • An assessment of the disease modeling tools compared to patient readouts

Exploration & Evaluation: How good are the model systems? What are we missing?

Meeting organisers:

Oxford Global

Speakers:

Barry Rosen, Vice President and Senior Principal Scientist AstraZeneca

Achim Kless, Scientific Director Grünenthal GmbH

Aaron Cheng, Head, Discovery Genome Editing GlaxoSmithKline